Other

Finance Lease Principal Paid

West Pharmaceutical Services Finance Lease Principal Paid remained flat by 0.0% to $300.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 50.0%, from $200.00K to $300.00K. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionOther
CategoryLeverage
SignalHigher is better
VolatilityStable
First reportedQ2 2023
Last reportedQ1 2026Apr 23, 2026

How to read this metric

Higher principal payments indicate active deleveraging of lease-related debt obligations.

Detailed definition

This represents the cash outflow used to reduce the principal balance of finance lease liabilities. It is a financing ac...

Peer comparison

Standard financing cash flow metric for companies with significant capital lease obligations.

Metric ID: cvx_finance_lease_principal_paid

Historical Data

9 periods
 Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$0.00$0.00$100.00K$22.90M$300.00K$200.00K$300.00K$300.00K$300.00K
QoQ Change>999%-98.7%-33.3%+50.0%+0.0%+0.0%
YoY Change+100.0%-98.7%+0.0%+50.0%
Range$0.00$22.90M
Avg YoY Growth+12.8%
Median YoY Growth+25.0%
Current Streak3 quarters growth

Frequently Asked Questions

What is West Pharmaceutical Services's finance lease principal paid?
West Pharmaceutical Services (WST) reported finance lease principal paid of $300.00K in Q1 2026.
How has West Pharmaceutical Services's finance lease principal paid changed year-over-year?
West Pharmaceutical Services's finance lease principal paid increased by 50.0% year-over-year, from $200.00K to $300.00K.
What does finance lease principal paid mean?
The cash used to pay down the principal of finance lease debt.